Skip to content
Politically.com Search all
Menu

2026 · 3rd Quarter (July 1 - Sep 30)

BIOFLORIDA, INC.

Filed by BUCHANAN INGERSOLL & ROONEY PC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-11-02 06:26:10 UTC.

Source-reported fields

Filing overview

Type
3rd Quarter - Report
Posted
Oct 20, 2026
Income
$20,000.00
Expenses
Not reported
Filing UUID
1ddee9dc-f64e-4d89-90dd-e9c177b99342
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

CPT · Copyright/Patent/Trademark

Issues relating to Florida life sciences industry including biopharma, medtech, digital health and health systems.

HCR · Health Issues

Issues relating to Florida life sciences industry including biopharma, medtech, digital health and health systems.

MAN · Manufacturing

Issues relating to Florida life sciences industry including biopharma, medtech, digital health and health systems.

MED · Medical/Disease Research/Clinical Labs

Issues relating to Florida life sciences industry including biopharma, medtech, digital health and health systems.

MMM · Medicare/Medicaid

Issues relating to Florida life sciences industry including biopharma, medtech, digital health and health systems.

PHA · Pharmacy

Issues relating to Florida life sciences industry including biopharma, medtech, digital health and health systems.

BUD · Budget/Appropriations

Issues relating to Florida life sciences industry including biopharma, medtech, digital health and health systems.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.